|
The Case of the Missing Protein |
08/05/2025 - 8:00am to 9:00am EDT |
|
Critical appraisal of the ANNEXA-I randomized controlled clinical trial |
08/12/2025 - 8:00am to 9:00am EDT |
|
From Kidneys to Marrow: The Oxalate Odyssey / Accessing Duke Box for Inpatient guidelines Access |
08/19/2025 - 8:00am to 9:00am EDT |
|
Just Say No (if you can): High Risk Medications and Sickle Cell Disease/ QI for SCD: individualized pain plans |
08/26/2025 - 8:00am to 9:00am EDT |
|
Interpreting Peripheral Blood Smears |
09/02/2025 - 8:00am to 9:00am EDT |
|
Prefibrotic Myelofibrosis: The Middle Child |
09/09/2025 - 8:00am to 9:00am EDT |
|
Passport to Pancytopenia |
09/16/2025 - 8:00am to 9:00am EDT |
|
The Hematology T32 Training Program: Next Steps |
09/23/2025 - 8:00am to 9:00am EDT |
|
"VTE Risk with Estrogen-Gender Affirming Hormone Therapy: An Institutional Experience at the Duke Gender Clinic" |
09/30/2025 - 8:00am to 9:00am EDT |
|
Not So Benign – Review of SCD Arab-Indian Haplotype |
10/07/2025 - 8:00am to 9:00am EDT |
Facebook
X
LinkedIn
Forward